PROACTIS News

Cancer Research to Cut Costs & Increase Efficiencies with PROACTIS eProcurement

  • PROACTIS, the specialist in Spend Control and eProcurement, today announced a major deal with Cancer Research UK, the world's leading cancer charity dedicated to saving lives through research.
  • The charity has purchased the PROACTIS cloud eprocurement platform that is designed for the not-for-profit-sector and comprises of the key source-to-contract and purchase-to-pay solution areas on a 5-year subscription deal.
  • PROACTIS was chosen after a comprehensive evaluation process and will allow Cancer Research UK to reduce administration costs, improve finance controls, and ensure best value for what it spends on goods and services to support frontline services.
  • Cancer Research UK joins more than 30 PROACTIS Third Sector clients in the UK, including charities such as RSPCA, Action on Hearing Loss, Age UK, Peabody Trust and Royal British Legion. PROACTIS thoroughly understands this sector and provides solutions that directly address the challenges it faces.

About the Solution

  • PROACTIS will automate and streamline the entire day-to-day buying process; from request through authorisation, ordering, invoice processing, and payment via Accounts Payable. It will provide the linkages between employees, internal systems, and suppliers that leverage the agreements and contracts established by Procurement.
  • PROACTIS will also provide the charity's Procurement team with a framework of sourcing, contract, catalogue, and supplier management capabilities that enable them to utilise their organisation's full buying power, gain best value agreements, and maximise the percentage of "spend under management" across all categories of spend.
  • The PROACTIS solution is built on proven, enterprise-class Microsoft.NET technology that is "agnostic" towards surrounding systems and offers a framework for smooth integration to the charity's back office financial applications.
  • The flexible nature of the solution is also a considerable cost saving benefit; it will allow the charity to rapidly modify its finance and procurement processes in the face of regulatory and business change, with minimal investment in IT resource.

Supporting Quotes

  • "PROACTIS has plenty of experience in this area and after an extensive evaluation process, the company has demonstrated it can support the special requirements of not-for-profit organisations like ourselves. We look forward to working with them going forward." Bob Miles, Finance Director, Cancer Research UK.
  • Rod Jones, CEO at PROACTIS said: "We are delighted to welcome Cancer Research UK to our extensive not-for-profit client base. The implementation of PROACTIS will help Cancer Research UK to use resources efficiently, achieve measurable results, and ensure accountability to supporters, partners and, most of all, the people it serves."
 
Stay Updated
Keep up to date with PROACTIS news, events and best practice